04/02/2020
In this video, Dr Hudesman, from NYU Langone Health, highlights the management of inflammatory bowel disease with lymphoma, discusses if a patient should restart therapy with a thiopurine after managing lymphoma, and key takeaways for gastroenterologists about treating patients with IBD and underlying malignancy.
Additional Resources:
David Hudesman, MD, is codirector of the Inflammatory Bowel Disease Center at NYU Langone Health and associate professor in the Department of Medicine at NYU Langone Health in New York, New York.